IL13 rs20541: Understanding the Arg130Gln Variant
The rs20541 variant is a well-studied genetic change in the IL13 gene that results in an amino acid substitution known as Arg130Gln. This variant is frequently investigated for its potential role in modulating immune system activity and its association with elevated IgE levels and atopic conditions.
What each genotype means
Increased atopic risk
This genotype is associated with higher IL-13 activity, which may increase your predisposition to elevated IgE levels and atopic conditions like asthma or allergic rhinitis. Research suggests this variant can influence immune responses, though individual risk is complex and depends on many environmental and genetic factors.
This is a common genotype, though its prevalence varies significantly across different global populations.
Intermediate atopic risk
Carrying one copy of each allele suggests an intermediate level of IL-13 activity compared to those with two copies of the risk-associated allele. You may have a moderate predisposition to atopic reactions, but this is not a diagnostic indicator and does not guarantee the development of any specific condition.
This heterozygous genotype is frequently observed in both European and Asian populations.
Baseline atopic profile
This genotype is generally considered the baseline or reference state for this variant in many studies. While it is associated with lower IL-13 receptor affinity compared to the C allele, it does not preclude the development of allergies or asthma, as these conditions are influenced by a wide range of genetic and environmental factors.
This genotype is common, with frequencies varying by ancestry, and is found in a significant portion of the general population.
What is the rs20541 Variant?
The rs20541 variant is a single nucleotide polymorphism (SNP) located within the IL13 gene on chromosome 5q31.1. In genetic terms, this variant is a coding missense mutation, meaning the change in the DNA sequence results in a different amino acid being incorporated into the final protein. Specifically, it causes an arginine to be replaced by a glutamine at position 130 of the IL-13 protein, often referred to as the Arg130Gln or R130Q substitution. Because this change occurs in the coding region of the gene, it has the potential to alter the structure and function of the resulting protein. Researchers study this specific site because it is located in a region of the protein that interacts with cellular receptors, leading to hypotheses that this variant might change how the immune system signals during an inflammatory response.
The Role of the IL13 Gene
The IL13 gene provides instructions for creating the interleukin-13 protein, a cytokine that acts as a critical signaling molecule in the immune system. Interleukin-13 is primarily secreted by T helper type 2 (Th2) cells and plays a central role in allergic inflammation. It helps regulate the immune response by promoting the production of IgE antibodies by B cells and influencing the activity of macrophages and smooth muscle cells. By modulating these processes, IL-13 is a key mediator in the body's defense against parasites, but it is also heavily involved in the pathogenesis of allergic diseases. Because of its central role in these pathways, variations in the IL13 gene are frequently examined to understand why some individuals may have a higher predisposition to allergic reactions or inflammatory conditions compared to others.
Research Associations and Evidence Strength
Scientific research has explored the link between rs20541 and various atopic phenotypes, including asthma, eczema, and allergic rhinitis. Many studies have observed statistical associations between this variant and elevated total serum IgE levels or increased eosinophil counts. For instance, some case-control studies have suggested that individuals carrying the variant may have a higher risk for conditions like eczema or bronchial asthma. However, it is important to note that the evidence strength for these associations is considered limited. Genetic associations can be complex, and results often vary significantly between different populations and study designs. While some research indicates a potential impact on receptor affinity, these findings do not imply a direct cause-and-effect relationship for any individual. The scientific community continues to investigate how this variant interacts with other genetic and environmental factors to influence immune health.
Population Frequency
The frequency of the rs20541 variant varies across different ancestral groups, which is a common observation in human genetics. Data indicates that the minor allele frequency is approximately 0.24 in European populations and rises to about 0.35 in Asian populations. These differences highlight that the prevalence of specific genetic variants is not uniform globally. Understanding these frequency distributions is essential for researchers when interpreting the results of genetic association studies, as it helps ensure that findings are contextualized within the appropriate ancestral background. Because this variant is relatively common in many populations, it is considered a standard polymorphism rather than a rare mutation.
Interpreting Your Genetic Information
Information regarding the rs20541 variant is intended for educational purposes and should not be used for medical diagnosis or to guide personal health decisions. Genetic variants like rs20541 represent only one small piece of a much larger puzzle involving your overall health, lifestyle, and environment. If you are concerned about symptoms related to allergies, asthma, or other immune-related conditions, it is essential to consult with a qualified healthcare professional. They can provide appropriate clinical evaluations, diagnostic testing, and personalized management plans. Never use genetic data to alter prescribed medications or treatment regimens without first discussing these changes with your doctor or pharmacist. Genetic testing can provide interesting insights into your biological makeup, but it cannot replace the expertise of a medical provider who understands your full clinical history.
How common is this variant?
The minor allele frequency for rs20541 is approximately 0.24 in European populations and 0.35 in Asian populations.
Frequently asked questions
Does having the rs20541 variant mean I will develop asthma?
No, having this variant does not mean you will develop asthma. Genetic variants are only one factor in a complex mix of genetics, environment, and lifestyle that influence health.
Can I use this information to change my allergy medication?
No. You should never change your medication or treatment plan based on genetic information. Always discuss any changes to your health management with your doctor or pharmacist.
Is rs20541 the same as the R130Q mutation?
Yes, rs20541 is the identifier for the SNP that causes the Arg130Gln (R130Q) amino acid change in the IL-13 protein.
Why do different populations have different frequencies of this variant?
Differences in allele frequencies across populations are common and result from human evolutionary history, migration patterns, and natural selection over thousands of years.
Sources & further reading
Educational information only, last refreshed 9/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs20541?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL13
Located near the IL13 locus, this non-coding variant modulates cytokine production and is associated with allergic rhinitis, atopic asthma, and elevated total serum IgE.
Variant in the TERT gene (often misattributed to IL13 in older literature) associated with cancer risk across multiple populations.
IL13 variant associated with elevated IgE and allergic/atopic tendencies.
IL13 R110Q alters cytokine signaling; associated with asthma and atopy.